Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Cash & Current Investments (2020 - 2025)

BioScience Health Innovations (BHIC) has disclosed Cash & Current Investments for 6 consecutive years, with $661925.0 as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments changed 0.09% to $661925.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $661925.0 through Dec 2025, changed 0.09% year-over-year, with the annual reading at $661925.0 for FY2025, 0.09% changed from the prior year.
  • Cash & Current Investments for Q4 2025 was $661925.0 at BioScience Health Innovations, down from $1.1 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $1.3 million in Q2 2025, with the low at $374.0 in Q2 2021.
  • Average Cash & Current Investments over 5 years is $285189.2, with a median of $56547.5 recorded in 2022.
  • The sharpest move saw Cash & Current Investments plummeted 98.36% in 2021, then skyrocketed 6439.04% in 2022.
  • Over 5 years, Cash & Current Investments stood at $96134.0 in 2021, then tumbled by 70.52% to $28343.0 in 2022, then tumbled by 32.12% to $19238.0 in 2023, then surged by 3343.79% to $662517.0 in 2024, then decreased by 0.09% to $661925.0 in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $661925.0, $1.1 million, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.